- Despite an analyst’s optimistic price target, GE HealthCare Technologies Inc. (NASDAQ:GEHC) shares recently fell due to a profit miss and reduced future guidance.
- The company reported adjusted earnings per share (EPS) of $0.99, falling short of the expected $1.06 for its first quarter.
- GE HealthCare lowered its full-year 2026 profit forecast, citing significant pressures from inflation-driven costs, particularly for memory chips, oil, and freight.
GE HealthCare is a global medical technology company, a key player in the competitive healthcare equipment industry. It specializes in producing medical imaging, monitoring, and diagnostic equipment. The company operates in a competitive market, facing other major players in the healthcare equipment industry. GE HealthCare‘s performance is closely watched by investors and analysts seeking investor insights into the sector.
On April 29, 2026, an analyst from Stifel Nicolaus set a new price target for GE HealthCare at $80. At that time, the stock’s price was $60.06. This new target suggested a potential upside, or increase in value, of approximately 33.2% from the price when the target was published, offering a positive outlook on the medical technology stock.
Despite this analyst optimism, GE HealthCare‘s shares recently fell 12.88% to a price of $59.68. The drop followed the company’s announcement of a profit miss and a cut to its future guidance, as highlighted by Proactive Investors. The stock performance even hit a new 52-week low of $58.75 during the day’s trading, reflecting market concerns.
For its first quarter, GE HealthCare reported adjusted earnings per share (EPS) of $0.99, which was below the expected $1.06. EPS represents the company’s profit divided by its number of shares. The company’s adjusted EBIT, a key measure of profitability, was $691 million, also missing the $734.50 million estimate in its latest earnings report.
The company lowered its full-year 2026 profit forecast, citing pressures from inflation-driven costs, as highlighted by Reuters. GE HealthCare specifically points to rising prices for memory chips, oil, and freight for the reduced outlook, as highlighted by The Wall Street Journal. The new adjusted EPS guidance is now between $4.80 and $5.00, indicating the significant inflation impact on earnings.
